CALL - SPRINTER OPEN END - MERCK & CO. | Delayed Deutsche Boerse AG 09:12:56 01/07/2024 BST | ||
| 2.94 EUR | -11.45% |
|
| Current month | +11.41% | ||
| 1 month | +8.85% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 01/07/24 | 2.94 | -11.45% |
| 28/06/24 | 3.32 | -0.30% |
| 27/06/24 | 3.33 | -9.76% |
| 26/06/24 | 3.69 | -1.86% |
| 25/06/24 | 3.76 | +2.17% |
Delayed Quote Deutsche Boerse AG
Last update July 01, 2024 at 09:12 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Vontobel
|
| WKN | VM5436 |
| ISIN | DE000VM54369 |
| Date issued | 29/11/2023 |
| Strike | 93.56 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.79 € |
|---|---|
| Lowest since issue | 1.02 € |
| Spread | 0.07 € |
| Spread % | 2.35% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8
USD
Average target price
142.7
USD
Spread / Average Target
+15.25%
- Stock Market
- Certificates
- Certificat
